16 June 2020>: Clinical Research
Lower Platelet Aggregation Is a Risk Factor for Dual Antiplatelet Therapy-Associated Bleeding: A Preliminary Retrospective Study with Genotype Analysis
Dongdong Yuan 1ABCD , Xiangfen Shi 2BCD , Liping Guo 1BF , Gaobiao Wang 1BF , Yujie Zhao 1B , Yuling Yang 1B , Hanjuan Zhang 1B , Qiong Huang 1B , Yiqiang Yuan 1AE*DOI: 10.12659/MSM.923758
Med Sci Monit 2020; 26:e923758
Table 3 Distribution of arachidonic acid-induced platelet aggregation rates in patients with reported bleeding events.
ACA-induced platelet aggregation (%) | Patients (n=25) | % |
---|---|---|
0–5 | 5 | 25% |
0–10 | 9 | 35% |
0–15 | 15 | 60% |
0–18 | 18 | 70% |
0–25 | 23 | 90% |
0–30 | 25 | 100% |
ACA – arachidonic acid. |